Qiming Venture Capital has led a US$8 million series A funding round in dMed Co., Ltd., a Chinese clinical contract research organization (CRO), with participation from Tairui Investment and ZAI Laboratory. The company says that it will use the latest proceeds to expedite the expansion of its current team, including assurance and clinical operations professionals, […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.